Hoth Therapeutics Inc.
13F holders, Q3 2025 (September 30)1holders
1new positions
0sold out
$1.62avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Hoth Therapeutics Inc. in their 13F filings, unchanged from Q3 2024. 1 opened new positions and 0 sold out. The largest holder was Farther Finance Advisors, LLC ($724).
- Company
- Hoth Therapeutics Inc.
- CUSIP
- 44148G105
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $724 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q3 2025: 447 shares bought, net +447 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Farther Finance Advisors, LLC | 0.00% | New | 447 | $724 |
"% of holder's portfolio" is HOTH THERAPEUTICS INC's weight in each manager's 13F, not the share of Hoth Therapeutics Inc. the manager owns.